Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C55H59N5O20 |
| Molecular Weight | 1110.0785 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@@H]1[C@@H](OC(=O)C2=CC=C(C)N2)[C@@H](O)[C@H](OC3=C(C)C4=C(C=C3)C(O)=C(NC(=O)C5=CNC(C(=O)NC6=C(O)C7=C(OC6=O)C(C)=C(O[C@@H]8OC(C)(C)[C@H](OC)[C@@H](OC(=O)C9=CC=C(C)N9)[C@H]8O)C=C7)=C5C)C(=O)O4)OC1(C)C
InChI
InChIKey=WTIJXIZOODAMJT-DHFGXMAYSA-N
InChI=1S/C55H59N5O20/c1-21-12-16-29(57-21)48(67)77-42-38(63)52(79-54(6,7)44(42)71-10)73-31-18-14-26-36(61)34(50(69)75-40(26)24(31)4)59-46(65)28-20-56-33(23(28)3)47(66)60-35-37(62)27-15-19-32(25(5)41(27)76-51(35)70)74-53-39(64)43(45(72-11)55(8,9)80-53)78-49(68)30-17-13-22(2)58-30/h12-20,38-39,42-45,52-53,56-58,61-64H,1-11H3,(H,59,65)(H,60,66)/t38-,39-,42+,43+,44-,45-,52-,53-/m1/s1
| Molecular Formula | C55H59N5O20 |
| Molecular Weight | 1110.0785 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Coumermycin is from the aminocoumarin class of antibiotic compounds which acts by inhibiting DNA gyrase. Coumermycin is effective against gram-positive bacteria, but not gram-negative bacteria. Coumermycin its derivatives have been studied since the 1950's as potential antibiotic. However, it has seen little to no clinical development because of its low water solubility, toxicity profile, and ineffectiveness against gram-negative bacteria.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2311224 Sources: https://www.ncbi.nlm.nih.gov/pubmed/794878 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV. | 2015-01-09 |
|
| Combinatorial biosynthesis, metabolic engineering and mutasynthesis for the generation of new aminocoumarin antibiotics. | 2008 |
|
| Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice. | 1988-03 |
|
| Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. | 1976-12 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3164157
Lethal septicemia was induced in mice by intraperitoneal administration of Methicillin-Resistant Staphylococcus. The infection was successfully treated in 50% of the animals (ED50) following a dose of 0.9 micro-g/g body weight. This was significantly better than ofloxacin and vancomycin.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4391844
The antibiotic ability of coumermycin was evaluated against 232 bacterial strains. Minimal inhibitory concentrations (MIC) were determined in trypticase soy broth using twofold serial dilutions. The last tube in a series to show no visible growth after 18 hours at 37 deg-C was considered the MIC. Strain specific MIC's were reported between 0.002 micro-g/L and 100 micro-g/L.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 06:53:12 GMT 2025
by
admin
on
Wed Apr 02 06:53:12 GMT 2025
|
| Record UNII |
PCH9QZ1IIH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C258
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3907
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
Coumermycin A1
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
DTXSID901023379
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
100000084272
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
54675768
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
SUB06814MIG
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
C81447
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
DB13912
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
4434-05-3
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
C004628
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
CHEMBL1908352
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
1948
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
PCH9QZ1IIH
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY | |||
|
107412
Created by
admin on Wed Apr 02 06:53:12 GMT 2025 , Edited by admin on Wed Apr 02 06:53:12 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |